The global anti-inflammatory therapeutics market size was US$ 94,511 million in 2021. The global anti-inflammatory therapeutics market is forecast to grow to US$ 130,711.1 million by 2030 by registering a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2022 to 2030.

Inflammation is caused when the body's defense system responds to harmful stimuli, irritants, damaged cells, and microorganisms. Innate immunity uses inflammation as a method to remove the source of the injury, eliminate the dead and necrotic cells, and heal the injured tissues. Anti-inflammatory autoimmune diseases occur when the body's defense system incorrectly initiates inflammation against its cells.

Factors Influencing the Market

Increasing use of anti-inflammatory drugs is primarily driving the growth of the global anti-inflammatory therapeutics market. In addition, individuals' per capita income in developing countries is increasing, which is surging the adoption of expensive medicines and boosting the market growth.

Improved access to healthcare facilities, combined with developments in the healthcare sector, will also escalate the growth of the global anti-inflammatory therapeutics market. On the contrary, the side effects of anti-inflammatory drugs may limit the market growth during the study period.

Growing awareness of anti-inflammatory therapeutics, combined with the rising prevalence of chronic diseases, will benefit the anti-inflammatory therapeutics market during the study period.

Regional Analysis

The Asia-Pacific anti-inflammatory therapeutics market is forecast to emerge as the largest market, which is attributable to the dense population in countries like India and China. Furthermore, improving healthcare infrastructure and the rapidly developing R&D sector will also benefit the anti-inflammatory therapeutics market.

An increase in the number of hospitals in emerging countries and growing initiatives by governments through healthcare reforms are expected to escalate the growth of the market. In addition to that, the growing adoption of technologically advanced products will amplify the anti-inflammatory therapeutics market growth during the study period.

COVID-19 Impact Analysis

The wake of the COVID-19 pandemic has disrupted the situation for various industries, including healthcare. However, the market witnessed the positive impact of the pandemic due to the inflammation caused by COVID-19. Various cases of COVID-19 witnessed severe anti-inflammatory pneumonia, which amplified the market growth. Moreover, various consequences of severe inflammation and cytokine storms, such as acute lung injury, and multiple organ dysfunction syndromes, surged the demand for anti-inflammatory drugs. In addition to that, R&D activities related to anti-inflammatory therapeutics drugs also increased abruptly to cure the patients. As a result, the pandemic has been beneficial for the anti-inflammatory therapeutics market.

Competitors in the Market

Eli Lily and Company
AstraZeneca PLC
Amgen Inc.
F. Hoffman
Abbvie, Inc.
Johnson & Johnson
GlaxoSmithKline
Merck & CO., Inc.
Novartis
Pfizer, Inc.
La Roche AG
Ferring Pharmaceuticals
Bioventus
Zimmer Biomet Holdings, Inc.
Flexion Therapeutics, Inc.
Other Prominent Players
Market Segmentation

The global anti-inflammatory therapeutics market segmentation focuses on Drug Class, Treatment, End-Users, and Region.

By Drug Class Outlook

Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
Corticosteroids
Biologics
By Treatment Outlook

Arthritis
Respiratory Disease
Multiple Sclerosis
Psoriasis
Anti-inflammatory Bowel Disease (IBD)
Other Anti-Inflammatory Diseases
By End-Users Outlook

Hospitals
Homecare
Specialty Clinics
Others
By Regional Outlook

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America